Also in some instances, the medium chain triglyceride as shown in below tables is replaced with a mixture of mixture of long-chain triglyceride and medium-chain triglycerides (0.1:99.9 to 99.9:0.1), The formulation is prepared by dissolving the appropriate amount of a JNK inhibitor and one or more than one of the viscosity modulating agents, such as PVP, carbomer, and P407, in water for injection and sterile filtering the solution
Factors affecting optimal GHK-CU dose Individual variation means the same dose produces different results in different people
[DOI] [PubMed] [Google Scholar] 18.Sikiric P, Seiwerth S, Grabarevic Z, et al
Denny CA, Burghardt NS, Schachter DM, Hen R, Drew MR
Next steps Continue your CopperTheory routine Use one clean pathway from this guide into the most relevant products, collections and education pages